Literature DB >> 15888030

The influence of phosphatidylinositol 3-kinase/Akt pathway on the ischemic injury during rat liver graft preservation.

Xian Liang Li1, Kwan Man, Kevin T Ng, Chris K Sun, Chung Mau Lo, Sheung Tat Fan.   

Abstract

We aimed to investigate the role of phosphatidylinositol 3 (PI3)-kinase/Akt pathway on ischemic injury. Rat liver grafts were preserved in UW solution with different treatments and were compared by 1-week survival rates and morphological changes with those of the control group. PI3-kinase/Akt was significantly activated at the sites of Thr 308 and Ser 473 in the preserved grafts. Downstream target proteins, glycogen synthase kinase-3beta (GSK-3beta) and caspase-9, were inactivated. However, survival signal transduction from Akt to Bad was blocked by calcium release after activation of PI3-kinase/Akt. Significant activation of caspase-12, -3 and -7 contributed to cell apoptosis and severe ischemic injury was shown after 7 h of preservation by UW solution with insulin. Downregulation of phospho-Akt at Thr 308 and Ser 473 was due to partial inhibition of PI3-kinase/Akt pathway by LY294002. Activation of GSK-3beta and inactivation of caspase-12 and Bad could be found in the LY294002 groups in which the liver grafts showed less ischemic injury. Higher 1-week survival rates in the heparin, LY294002, and glucagon groups confirmed the dysregulation of the pathway. In conclusion, PI3-kinase/Akt pathway was dysregulated and contributed to ischemic injury during preservation. Heparin and LY294002 could improve graft viability by maintaining calcium homeostasis during preservation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888030     DOI: 10.1111/j.1600-6143.2005.00877.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  8 in total

1.  Human catestatin peptides differentially regulate infarct size in the ischemic-reperfused rat heart.

Authors:  Bhawanjit K Brar; Erik Helgeland; Sushil K Mahata; Kuixing Zhang; Daniel T O'Connor; Karen B Helle; Anne K Jonassen
Journal:  Regul Pept       Date:  2010-07-22

2.  Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.

Authors:  Valerie Zabala; Ming Tong; Rosa Yu; Teresa Ramirez; Emine B Yalcin; Silvia Balbo; Elizabeth Silbermann; Chetram Deochand; Kavin Nunez; Stephen Hecht; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2015-01-24       Impact factor: 2.826

3.  Beta-catenin promotes survival of renal epithelial cells by inhibiting Bax.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan M Gall; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

4.  GSK3beta promotes apoptosis after renal ischemic injury.

Authors:  Zhiyong Wang; Andrea Havasi; Jonathan Gall; Ramon Bonegio; Zhijian Li; Haiping Mao; John H Schwartz; Steven C Borkan
Journal:  J Am Soc Nephrol       Date:  2010-01-21       Impact factor: 10.121

Review 5.  The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.

Authors:  M Mendes-Braz; M Elias-Miró; M B Jiménez-Castro; A Casillas-Ramírez; F S Ramalho; C Peralta
Journal:  J Biomed Biotechnol       Date:  2012-05-09

Review 6.  Autophagy and liver ischemia-reperfusion injury.

Authors:  Raffaele Cursio; Pascal Colosetti; Jean Gugenheim
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

Review 7.  The liver-brain axis of alcohol-mediated neurodegeneration: role of toxic lipids.

Authors:  Suzanne M de la Monte; Lisa Longato; Ming Tong; Sarah DeNucci; Jack R Wands
Journal:  Int J Environ Res Public Health       Date:  2009-07-23       Impact factor: 3.390

8.  Lycium barbarum polysaccharide induced apoptosis and inhibited proliferation in infantile hemangioma endothelial cells via down-regulation of PI3K/AKT signaling pathway.

Authors:  Lin Lou; Guo Chen; Bing Zhong; Feng Liu
Journal:  Biosci Rep       Date:  2019-08-19       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.